PieTrader Stock Summary
Democratizing hedge fund level analysis tools for everyone
Actions
PT Kalbe Farma Tbk, together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. It operates in four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe Farma Tbk is a subsidiary of PT Gira Sole Prima.. (KLBF)
Visit WebsiteProfile
| Name | Kalbe Farma Tbk. |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
Shareholders
| Name | Latest % | A Month Ago % |
|---|---|---|
| Public < 5% | 38.47 | 38.47 |
| Ladang Ira Panen Pt | 10.47 | 10.47 |
| Gira Sole Prima Pt | 10.31 | 10.31 |
| Santa Seha Sanadi Pt | 10.08 | 10.08 |
| Lucasta Murni Cemerlang Pt | 9.48 | 9.48 |
| Diptanala Bahana Pt | 9.3 | 9.3 |
| Bina Arta Charisma Pt | 8.21 | 8.21 |
| Treasury Shares | 3.34 | 3.34 |
| Ronny Hadiana | 0.2 | 0.2 |
| Santoso Oen | 0.09 | 0.09 |
| B. R. Irawati Setiady | 0.05 | 0.05 |
| Herijanto Irawan | 0.0 | 0.0 |
| Jos Iwan Atmadjaja | 0.0 | 0.0 |
| Kartika Setiabudy | 0.0 | 0.0 |
| Mulialie | 0.0 | 0.0 |
| Sidharta Utama | 0.0 | 0.0 |
Revenue Breakdown
| Source | 2022 | 2021 |
|---|---|---|
| 2019 | KLBF | F2 |
| 2020 | KLBF | F2 |
| 2021 | KLBF | F2 |
| 2022 | KLBF | F2 |
| 2023 | KLBF | F2 |
| 2024 | KLBF | F2 |
| Region | 2022 | 2021 |
|---|---|---|
| 1225 | KLBF | F2 |
| 1226 | KLBF | F2 |
| 1227 | KLBF | F2 |
Financial Statement Analysis
Price Chart
Valuation vs. Industry
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 0.95 | # 11 / 15 |
| EV_EBITDA | 6.15 | # 5 / 15 |
| PER | 9.63 | # 7 / 15 |
| PBV | 1.38 | # 8 / 15 |
| DER | 0.03 | # 6 / 15 |
Profitability vs. Industry
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | 9.85412092784953 | # 4 / 15 |
| ROA % | 11.61 | # 4 / 15 |
| ROE % | 14.37 | # 6 / 15 |
Dividends
| Year | DPS | Yield [%] |
|---|---|---|
| 2026 | 20.0 | 2.5 |
| 2025 | 36.0 | 3.0 |
| 2024 | 31.0 | 2.3 |
| 2023 | 38.0 | 2.4 |
| 2022 | 35.0 | 1.7 |
| 2021 | 28.0 | 1.7 |
| 2020 | 26.0 | 1.8 |
| 2019 | 26.0 | 1.8 |
Performance
| Timeframe | Performance |
|---|---|
| 1W % | 9.0 |
| 1Mo % | 9.0 |
| 3Mo % | 0.4 |
| 1Yr % | -31.0 |
Historical Valuations
Snowflake Chart
Seasonality
Peers Comparison
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 9.63 | 36.98 T | 32.98 T | 38,958 B | 5,365 B | 3,839 B |
| SOHO | 20.50 | 15.29 T | 14.58 T | 10,725 B | 980 B | 746 B |
| TSPC | 8.24 | 12.76 T | 8.61 T | 14,220 B | 1,885 B | 1,550 B |
| SIDO | 16.01 | 10.68 T | 10.21 T | 2,933 B | 959 B | 667 B |
| MDLA | 6.59 | 2.91 T | 2.75 T | 16,342 B | 643 B | 442 B |
| KAEF | 123.99 | 2.56 T | 8.59 T | 9,403 B | 627 B | 21 B |